BME:SCGLR Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Other Revenue	10.51	-	-
Total Revenue	10.51	-	-
Revenue Growth (YoY	-	-	-
Selling, General & Administrative	0.4	0.01	0
Other Operating Expenses	-	-	0
Total Operating Expenses	0.4	0.01	0
Operating Income	10.11	-0.01	-0
Interest & Investment Income	-	0	0
Other Non-Operating Income	-0	-0	-0
EBT Excluding Unusual Items	10.11	-0.01	-0
Pretax Income	10.11	-0.01	-0
Income Tax Expense	0	-0	-0
Net Income	10.11	-0	-0
Net Income to Common	10.11	-0	-0
Net Income Growth	-	-	-
Basic Shares Outstanding	5	5	-
Diluted Shares Outstanding	5	5	-
Shares Change	2.59%	-	-
EPS (Basic)	2.06	-0.00	-
EPS (Diluted)	2.06	-0.00	-
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Margin	96.18%	-	-
Profit Margin	96.16%	-	-
EBIT	10.11	-0.01	-0
EBIT Margin	96.18%	-	-
Effective Tax Rate	0.01%	-	-
Revenue as Reported	10.51	-	-